Best Immunotherapy for lung cancer Doctors in Istanbul for Australians

Associate Professor Eda Tanrikulu ranked 3rd nationwide in Turkey's medical specialty exams and leads international clinical trials for new cancer therapies.

• Completed a specialized lung cancer preceptorship at The Christie in Manchester
• Focuses on matching biological treatments to the unique genetic profile of tumours
• Former Head of the Medical Oncology Unit at Haydarpaşa Numune Training Hospital
• Member of the European Society for Medical Oncology (ESMO)
• Uses targeted therapy and immunotherapy for advanced malignant diseases

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Professor Mustafa Solak completed a prestigious fellowship at the University of Texas MD Anderson Cancer Centre – one of the world's most renowned cancer institutions.

• Specialises in administering immunotherapy treatments like Keytruda for advanced lung malignancies
• Trained at the Hacettepe University Cancer Institute in medical oncology
• Focuses on evidence-based systemic therapies for complex solid tumours
• Manages targeted therapy protocols to improve outcomes in late-stage cases
• Experienced in coordinating multi-disciplinary care at Hisar Hospital Intercontinental

Professor Sezer Sağlam is a senior medical oncologist at Gayrettepe Florence Nightingale Hospital with a professional focus on complex tumour management.

• Holds full professorship in oncology from Istanbul University Oncology Institute
• Maintains active membership in the American Society of Clinical Oncology (ASCO)
• Member of the European Society for Medical Oncology (ESMO)
• Specialised in gastrointestinal oncology and neuroendocrine tumours
• Practises at a major hospital within the prestigious Florence Nightingale network

Associate Professor Abdullah Sakin is a leading medical oncologist who served as the Head of the Medical Oncology Department at Yüzüncü Yıl University.

• Specialises in managing complex lung cancer cases using modern immunotherapy protocols
• Served as an Education Officer at the prestigious Prof Dr Cemil Taşçıoğlu City Hospital
• Fellowship trained in medical oncology at the Okmeydanı Training and Research Hospital
• Expertise includes combining targeted therapies with internal medicine for holistic patient care
• Board-certified specialist in both internal medicine and medical oncology

Dr Sinan Karaaslan is a specialist medical oncologist at Anadolu Medical Center, a facility affiliated with the prestigious Johns Hopkins Medicine.

• Focuses on systemic therapies for stage 4 lung cancer cases
• Utilises modern immunotherapy and targeted therapy protocols for lung malignancies
• Active member of the Turkish Lung Cancer Society
• Previously served as an oncology expert at the Gülhane Military Medical Academy
• Completed advanced medical oncology fellowship at Istanbul University Cerrahpaşa Medical School

Professor Yesim Yildirim completed specialised immuno-oncology training at Mount Vernon Cancer Center in the UK and serves as a lead oncologist at Anadolu Medical Center.

• Holds European Society for Medical Oncology (ESMO) certification
• Specialises in immunotherapy and targeted biology for lung cancer
• Published over 80 scientific works on precision medicine
• Founder of the Turkish Gastrointestinal Oncology Network
• Completed advanced immunology training in Switzerland via a Hans Wyder Fellowship

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Professor Sezer Saglam is a senior medical oncologist at Istanbul Florence Nightingale Hospital with high-level expertise in complex cancer protocols.

• Holds a professorship in medical oncology since 2016
• Active member of the American Society of Clinical Oncology (ASCO)
• Maintains international standards through membership with the European Society for Medical Oncology (ESMO)
• Specialised fellowship training at the prestigious Istanbul University Oncology Institute
• Member of the European Neuroendocrine Tumour Society (ENETS)

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Associate Professor Tahsin Ozatli is a specialist medical oncologist at Istinye University Liv Hospital with a focused clinical interest in treating lung and gastrointestinal tumours.

• Holds the academic rank of Associate Professor – a title reflecting high-level clinical expertise and research contributions
• Gained specialised oncology experience at the Ankara Oncology Clinic in Turkey
• Served as a physician in the Oncology Department at Erzurum Regional Training and Research Hospital
• Focuses on targeted systemic therapies for complex lung cancer cases

Professor Cemil Bilir is a distinguished medical oncologist who completed a prestigious fellowship at Northeastern University's Center for Pharmaceutical Biotechnology and Nanomedicine in Boston.

• Holds a Professor title at Sakarya University Faculty of Medicine
• Completed international postgraduate rotations at the world-renowned Cleveland Clinic
• Pursuing a PhD in Inorganic Chemistry to advance his knowledge of drug interactions
• Active member of the European Society for Medical Oncology (ESMO)
• Participates in global research via the American Society of Clinical Oncology (ASCO)

Dr. Nail Paksoy is an associate professor of medical oncology at Medipol Bahçelievler Hospital. He is board-certified by the European Society for Medical Oncology (ESMO). Dr. Paksoy specializes in lung, breast, and gastrointestinal cancers. He uses modern immunotherapy and targeted therapy protocols. His clinic is JCI-accredited for high safety standards.

• Served as a subinvestigator in over 8 international clinical trials for Roche and Pfizer.
• Authored over 40 research articles in journals indexed by SCI and SSCI.
• Completed dual fellowships in allergy-immunology and medical oncology.
• Treats complex sarcomas and renal cell carcinomas with systemic therapies.

Professor Ercan Ozden is a medical oncology specialist at VM Medical Park Pendik who focus on targeted cancer therapies. He completed his internal medicine training at Istanbul University Cerrahpasa Faculty of Medicine.

• Specialises in medical oncology and subspecialty internal medicine
• Expertise in managing systemic treatments for thoracic malignancies
• Graduated from the prestigious English Medical Programme at Istanbul University
• Practises at VM Medical Park – a major Turkish hospital group known for oncology

Associate Professor Muhammed Mustafa Atci is a lead medical oncologist at Istinye University Liv Hospital Topkapi and an Education Coordinator for oncology specialists.

• Specialises in non-small cell lung cancer and metastatic cases
• Published research on how body mass index and age impact lung cancer treatment outcomes
• Member of the American Society of Clinical Oncology (ASCO)
• Focuses on tailoring therapy based on clinical and pathological characteristics

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Associate Professor Atakan Topcu is a leading medical oncologist who combines targeted immunotherapy with a specialised focus on lung cancer patient recovery and well-being.

• Serves on the editorial board of BMC Cancer, a prestigious international peer-reviewed medical journal
• Specialises in managing immunotherapy side effects and cancer-related malnutrition in lung cancer cases
• Completed a clinical observership at the University of Leicester in the United Kingdom
• Published over 50 scientific articles focusing on solid tumours and immunotherapy outcomes
• Member of the European Society for Medical Oncology (ESMO)

Associate Professor Ayse Irem Yasin is an ESMO-certified oncologist who manages complex lung cancer cases at Medipol Acibadem District Hospital.

• Holds European Society for Medical Oncology (ESMO) board certification
• Completed clinical observerships at Cleveland Clinic and Harvard Medical School
• Specialises in treating lung adenocarcinomas and malignant melanomas
• Former specialist at Şişli Etfal Training and Research Hospital
• Focuses on targeted immunotherapy protocols for solid tumours